Drug Trial Radar · NCT04695327
TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy
Last checked: Nov 19, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Jan 11, 2021
Primary completion
Sep 3, 2025
Study completion Sep 3, 2025
Sponsor
- Lead sponsor
- TILT Biotherapeutics Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 5, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, phase 1, dose-escalation, multicenter trial evaluating the safety of oncolytic adenovirus TILT-123 as monotherapy in advanced solid tumor patients.
Conditions
- Solid Tumor
Interventions
TILT-123Biological
TNFalpha and IL-2 coding oncolytic adenovirus TILT-123
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with any (serious and non-serious) Adverse Events.Time frame: 85 days
- Number of Participants with abnormal laboratory values.Time frame: 85 days
- Number of Participants with vital sign abnormalities.Time frame: 85 days
- Number of Participants with Adverse Events assessed by 12- lead electrocardiograms (ECGs)Time frame: 85 days
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Helsinki University Hospital
Helsinki, Uusima, Finland
Docrates Cancer Center
Helsinki, Uusima, Finland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.